Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service aortic endografts (EVAR/TEVAR) cases in Indiana: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 10% on average (139 state-years, 2020–2024): read it as a direction with a margin.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 7 | 507 | 35% |
| 2020 | 6 | 378 | 39% |
| 2021 | 5 | 365 | 44% |
| 2022 | 3 | 366 | 47% |
| 2023 | 2 | 356 | 51% |
| 2024 | 4 | 350 | 53% |
| 2025 from claims | – | 376 304–442 | 54% |
| 2026 forecast | – | 379 297–476 | 55% |
| 2027 forecast | – | 380 281–502 | 55% |
| 2028 forecast | – | 380 269–525 | 56% |
| 2029 forecast | – | 381 259–546 | 57% |
| 2030 forecast | – | 382 250–566 | 57% |
Endovascular abdominal and thoracic aortic repair. Professional codes (what the surgeon bills): CPT 34701, 34702, 34703, 34704, 34705, 34706, 33880, 33881; the hospital bills MS-DRG 268, 269, 213, 209.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 100% of the cases CMS names in Indiana; 4 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 100% inpatient hospital.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Ohio | 3 | 615−5.9%/yr | −5.9%/yr | 0.6 | 0% | 460 in 2030−4.8%/yr |
| Illinois | 7 | 563−7.4%/yr | −7.4%/yr | 0.4 | 0% | 600 in 2030+1.1%/yr |
| Michigan | 0 | 381−11%/yr | −11%/yr | 0.5 | 0% | 370 in 2030−0.6%/yr |
| Missouri | 5 | 372−9.1%/yr | −9.1%/yr | 0.6 | 0% | 340 in 2030−1.6%/yr |
| Wisconsin | 1 | 197−8.5%/yr | −8.5%/yr | 0.4 | 0% | 270 in 2030+5.7%/yr |
| Minnesota | 0 | 187−8.9%/yr | −8.9%/yr | 0.4 | 0% | 190 in 2030+0.2%/yr |
| Kansas | 3 | 178−7.8%/yr | −7.8%/yr | 0.4 | 0% | 160 in 2030−1.9%/yr |
| Iowa | 1 | 169+0.7%/yr | +0.7%/yr | 0.4 | 0% | 210 in 2030+3.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 35 | 3,475−14%/yr | −14%/yr | 5.11.1× | 60% | 2,970 in 2030−2.6%/yr |
| Peripheral arterial intervention | 18 | 2,941−9.6%/yr | −9.6%/yr | 4.01.0× | 16% | 2,980 in 2030+0.2%/yr |
| Superficial venous ablation | 29 | 2,244−3.2%/yr | −3.2%/yr | 3.00.9× | 86% | 2,540 in 2030+2.1%/yr |
| Thrombectomy, IVC filters & venous stents | 7 | 1,264+6.5%/yr | +6.5%/yr | 1.81.3× | 15% | 1,940 in 2030+7.4%/yr |
| Carotid revascularization | 20 | 960−7.3%/yr | −7.3%/yr | 1.31.2× | 0% | 930 in 2030−0.5%/yr |
Aortic endografts (EVAR/TEVAR) in every state, and its device makers · Every procedure market in Indiana · Every state · Compare with Ohio
Endologix leads with 47% of company spending on these surgeons in 2025, +30 pts on 2024.
In 2025, 5 companies reported engagement with Indiana’s surgeons worth $63K in consulting, speaking, meals and travel tied to these products, about $16K per surgeon billing it. Royalties are left out.
FDA, last 12 months: 36 clearances and approvals in the category, 2 recalled product lines (1 Class I). A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.